13F Filings History of GSK plc
- Latest 13F filing
- Q2 2026 - 13 Aug 2026
- Latest reported 13F value
- $602,220,442
- Largest 13F holdings
-
CRSP WVE VIR BNTX IDYA CYTK LYEL SPRO NKTX FULC BCYC CVRX
+1 more
RGNX - Form 13F summary
-
- GSK plc Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- GSK plc reported 13 equity holdings with a total reported market value of $602,220,442 for Q2 2026. Top reported holdings included CRSP, WVE, VIR, BNTX, and IDYA.
- Manager signature
- Victoria Whyte - Authorised Signatory for and on behalf of GSK plc
- Manager location
- London
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow GSK plc with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2026
Latest value
$602,220,442
Quarter delta
+$3,067,062
Accepted
13 Aug 2026, 16:32
Rows shown
1-3 of 3
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | $602,220,442 | $0 | $0 | $0 | CRSP, WVE, VIR, BNTX, IDYA | 13F-HR | 13 Aug 2026, 16:32 |
| Q1 2026 | 13 | $599,153,380 | $0 | -$67,383 | -$67,383 | CRSP, WVE, BNTX, VIR, IDYA | 13F-HR | 14 May 2026, 16:45 |
| Q4 2025 | 15 | $799,022,938 | $0 | $0 | $0 | WVE, CRSP, BNTX, VIR, LYEL | 13F-HR | 12 Feb 2026, 16:29 |